Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Proton SBRT for medically inoperable stage I NSCLC.

Westover KD, Seco J, Adams JA, Lanuti M, Choi NC, Engelsman M, Willers H.

J Thorac Oncol. 2012 Jun;7(6):1021-5. doi: 10.1097/JTO.0b013e31824de0bf.

2.

Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review.

Palma D, Lagerwaard F, Rodrigues G, Haasbeek C, Senan S.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1149-56. doi: 10.1016/j.ijrobp.2011.03.005. Review.

3.

Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.

Aridgides P, Bogart J.

Thorac Surg Clin. 2016 Aug;26(3):261-9. doi: 10.1016/j.thorsurg.2016.04.008. Review.

PMID:
27427521
4.

Stereotactic body radiation therapy for stage I non-small cell lung cancer.

Chang JY, Roth JA.

Thorac Surg Clin. 2007 May;17(2):251-9. Review.

PMID:
17626403
5.

Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients.

Ceniceros L, Aristu J, Castañón E, Rolfo C, Legaspi J, Olarte A, Valtueña G, Moreno M, Gil-Bazo I.

Clin Transl Oncol. 2016 Mar;18(3):259-68. doi: 10.1007/s12094-015-1361-4. Review.

PMID:
26243396
6.

Stereotactic body radiotherapy for early stage lung cancer: History and updated role.

Ricardi U, Badellino S, Filippi AR.

Lung Cancer. 2015 Dec;90(3):388-96. doi: 10.1016/j.lungcan.2015.10.016. Review.

PMID:
26791797
7.
8.

Radiofrequency ablation for early-stage nonsmall cell lung cancer.

Hiraki T, Gobara H, Iguchi T, Fujiwara H, Matsui Y, Kanazawa S.

Biomed Res Int. 2014;2014:152087. doi: 10.1155/2014/152087. Review.

9.

The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer.

Guerrero E, Ahmed M.

Lung Cancer. 2016 Feb;92:22-8. doi: 10.1016/j.lungcan.2015.11.015. Review.

PMID:
26775592
10.

Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy?

Nguyen NP, Godinez J, Shen W, Vinh-Hung V, Gorobets H, Thariat J, Ampil F, Vock J, Karlsson U, Chi A; International Geriatric Radiotherapy Group..

Medicine (Baltimore). 2016 Oct;95(43):e5212. Review.

11.

Stereotactic body radiation therapy in the re-irradiation situation--a review.

Mantel F, Flentje M, Guckenberger M.

Radiat Oncol. 2013 Jan 5;8:7. doi: 10.1186/1748-717X-8-7. Review.

12.

Carbon ion therapy for early-stage non-small-cell lung cancer.

Demizu Y, Fujii O, Iwata H, Fuwa N.

Biomed Res Int. 2014;2014:727962. doi: 10.1155/2014/727962. Review.

13.

Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non-Small-cell Lung Cancer: A Systematic Review.

Falkson CB, Vella ET, Yu E, El-Mallah M, Mackenzie R, Ellis PM, Ung YC.

Clin Lung Cancer. 2017 Mar;18(2):105-121.e5. doi: 10.1016/j.cllc.2016.10.008. Review.

PMID:
27908621
14.

Radiation pneumonitis after stereotactic radiation therapy for lung cancer.

Yamashita H, Takahashi W, Haga A, Nakagawa K.

World J Radiol. 2014 Sep 28;6(9):708-15. doi: 10.4329/wjr.v6.i9.708. Review.

15.

Stereotactic radiotherapy for early stage non-small cell lung cancer.

Ricardi U, Badellino S, Filippi AR.

Radiat Oncol J. 2015 Jun;33(2):57-65. doi: 10.3857/roj.2015.33.2.57. Review.

16.

Supplemental Content

Support Center